title: Misoprostol use in the community to reduce maternal death.
authors.forename: A Metin
authors.initials: AM
authors.lastname: Gülmezoglu
authors.forename: Matthews
authors.initials: M
authors.lastname: Mathai
authors.forename: João Paulo
authors.initials: JP
authors.lastname: Souza
authors.forename: Catherine
authors.initials: C
authors.lastname: d'Arcangues
authors.forename: Michael
authors.initials: M
authors.lastname: Mbizvo
mesh_terms: D000328:Adult; D005260:Female; D006801:Humans; D008428:Maternal Mortality / Q000639:trends; D016595:Misoprostol / Q000008:administration & dosage* / Q000009:adverse effects; D010120:Oxytocics / Q000008:administration & dosage* / Q000009:adverse effects; D006473:Postpartum Hemorrhage / Q000188:drug therapy* / Q000401:mortality / Q000517:prevention & control*; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D014944:World Health Organization
chemical_list: D010120:Oxytocics; D016595:Misoprostol